Dr. Katelyn Lauren Gamson, MD

Dr. Gamson practices at California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California.

Dr. Gamson's NPI, 1679899736, was assigned on April 14, 2010. Dr. Gamson graduated from UCSF School of Medicine in 2010. Dr. Gamson holds California license A120331.

Dr. Gamson's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD, at 2333 Buchanan St, San Francisco, CA 94115.

Dr. Gamson's primary practice is California Pacific Medical Center - B.H. Cancer Care Center-Buchanan St - HOPD in San Francisco, California. Dr. Gamson is also affiliated with California Pacific Medical Center Van Ness Campus. The medical group on file is Pacific Inpatient Medical Group. Dmand AI also links Dr. Gamson to 3 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gamson practices, 5 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Gamson's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Gamson is board certified in internal medicine by the American Board of Internal Medicine. Dr. Gamson is licensed in California.

Dmand AI lists anemia, atrial fibrillation and flutter, bile duct problems, cardiac arrhythmia, chronic hypertension, chronic kidney disease, cirrhosis and congestive heart failure among the conditions Dr. Gamson treats.

CMS data shows 532 Medicare services from Dr. Gamson across 7 procedure codes in 2024, for 248 Medicare patients. Medicare paid $59,771 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 248 Medicare patients who saw Dr. Gamson in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 54% are also on Medicaid. Their average risk score is 2.61, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Gamson's median patient age at 69, with 47% women.

In 2024, Dr. Gamson wrote 117 Medicare Part D claims for 51 patients. 85% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $273 in total drug cost. In 2021, CMS named 11 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Gamson for performance year 2024, reported as part of a group. Dr. Gamson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 3 papers to Dr. Gamson, published from 2005 to 2013. Dr. Gamson's most frequent co-authors are Paul B. Aronowitz, MD, Yile Ding, MD and Yoav Golan, MD.

CMS Open Payments shows 3 general payments to Dr. Gamson from 1 drug or device company from 2016 to 2019. Food and beverage make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $302.

Dr. Gamson graduated from UCSF School of Medicine in 2010.

Dr. Gamson is in network with 1 carrier, including CMS Medicare. Medicare plans come from the most carriers, 1. Check the plan with the practice before a visit.